Author

M. Uhrberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

L. Walter· 2 shared A. Braun· 1 shared A. Huang· 1 shared A. Noll· 1 shared A. R. Manser· 1 shared C. Alter· 1 shared C. Bade-Doding· 1 shared C. Kirschning· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. Walter

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 modulates NK cell responses via induction of HLA-E and triggers expansion of adaptive NK cells during acute infection

M. Z. Hasan, M. Claus, N. Kruger, S. Reusing, E. Gall, C. Bade-Doding, A. Braun, C. Watzl, M. Uhrberg, L. Walter

This study shows SARS-CoV-2 increases HLA-E expression via spike protein processing, modulating NK cell function by affecting canonical and adaptive NK cells differently during acute infection.

bioRxiv · Mar 4, 2024Immunology

The mycotoxin Beauvericin exhibits immunostimulatory effects on dendritic cells via activating the TLR4 signaling pathway

X. Yang, S. Ali, M. Zhao, L. Richter, V. Schafer, J. S. Diecks, M. Frank, J. Qi, P. K. Larsen, J. Skerra, H. Islam, T. Wachtmeister, C. Alter, A. Huang, S. Bhatia, , S. Scheu

This study identifies Beauvericin as an activator of dendritic cells via the TLR4 signaling pathway, suggesting its potential as a vaccine adjuvant or cancer immunotherapy.

bioRxiv · Jan 20, 2022Immunology

Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells

S. B. Bennstein, S. Weinhold, A. R. Manser, N. Scherenschlich, A. Noll, K. Raba, G. Kögler, L. Walter, M. Uhrberg

The paper identifies a novel ILC1-like NK cell progenitor in umbilical cord blood that can differentiate into KIR+NKG2A- NK cells with diverse KIR repertoires.

bioRxiv · Jan 24, 2020Immunology